Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats

André Tomescot1, Julia Leschik, Valérie Bellamy

  • 1Institut National de la Santé et de la Recherche Médicale/Evry University Unité Mixte de Recherche 861, I-Stem, Association Française contre les Myopathies, 5, rue Desbrières, Evry 91030, France.

Insights

Human embryonic stem cells, when directed towards a cardiac lineage, demonstrated myocardial regenerative capacity after transplantation into infarcted rat hearts. These cardiac-specified stem cells successfully differentiated into cardiomyocytes without forming teratomas.

Area of Science:

  • Stem Cell Biology
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • Human embryonic stem (HES) cells can differentiate into cardiomyocytes in vitro.
  • The potential for undifferentiated HES cells to regenerate myocardium in vivo remains largely unestablished.
  • Investigating HES cell myocardial regenerative capacity is crucial for developing new cardiac therapies.

Purpose of the Study:

  • To determine if cardiac-specified HES cells possess myocardial regenerative capacity after in vivo engraftment.
  • To compare the efficacy of two HES cell lines (HUES-1 and I6) directed towards a cardiac lineage.
  • To assess the differentiation and safety of transplanted HES cells in a rat myocardial infarction model.

Main Methods:

  • Two HES cell lines were differentiated towards a cardiac lineage using bone morphogenetic protein-2 (BMP2) and SU5402.
  • Gene expression of mesodermal and cardiac markers was analyzed using real-time polymerase chain reaction (PCR).
  • Immunosuppressed rats with myocardial infarction received in-scar injections of HES cells or control medium, followed by analysis of cell differentiation and teratoma formation.

Main Results:

  • Cardiac-specified HES cells expressed key mesodermal and cardiac genes (Tbx6, Isl1, FoxH1, Nkx2.5, Mef2c, alpha-actin).
  • Human cells were detected in infarcted rat hearts 2 months post-transplantation and showed cardiomyocytic differentiation (anti-beta myosin expression).
  • No teratomas were observed in the hearts or other organs of transplanted rats.

Conclusions:

  • Cardiac-specified HES cells can differentiate into cardiomyocytes following transplantation into infarcted myocardium.
  • These findings suggest that HES cells hold promise as an effective therapeutic candidate for myocardial regeneration.
  • Further research into HES cell-based therapies could advance the treatment of heart disease.

Related Concept Videos